(Q44760389)

6 December 2017

Identification of HIV-1 protease cleavage site in human C1-inhibitor (English)

1 reference

6 December 2017

Marijan Gerencer

1

1 reference

PubMed ID

15325085

6 December 2017

Vitomir Burek

series ordinal

2

1 reference

6 December 2017

1 September 2004

1 reference

6 December 2017

1 reference

6 December 2017

105

1 reference

6 December 2017

97-100

1 reference

6 December 2017

1

1 reference

The protein information resource (PIR)

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Purification and characterization of the RNase H domain of HIV-1 reverse transcriptase expressed in recombinant Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Hepatitis C virus NS3 serine protease interacts with the serpin C1 inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Acquired deficiency of functional C1-esterase inhibitor in HIV type 1-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

The structural aspects of limited proteolysis of native proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

The effect of cleavage by a Crotalus atrox alpha-proteinase fraction on the properties of C1-inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

The structural basis for neutrophil inactivation of C1 inhibitor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Two-domain structure of the native and reactive centre cleaved forms of C1 inhibitor of human complement by neutron scattering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Angioedema and transient acquired C1 inhibitor functional deficiency in HIV infection: case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Non-viral cellular substrates for human immunodeficiency virus type 1 protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Limited proteolysis of C1-inhibitor by chymotrypsin-like proteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Complement Regulatory Protein C1 Inhibitor Binds to Selectins and Interferes with Endothelial-Leukocyte Adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

C1 inhibitor-C1s complexes are internalized and degraded by the low density lipoprotein receptor-related protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Calcium-free calmodulin is a substrate of proteases from human immunodeficiency viruses 1 and 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Human plasma proteinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

Antibody response to human immunodeficiency virus type 1 protease according to risk group and disease stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.04.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2004.04.010

1 reference

6 December 2017

1 reference

PubMed ID

15325085